194 related articles for article (PubMed ID: 415005)
1. Activation of the alternate complement pathway by peptidoglycan from streptococcal cell wall.
Greenblatt J; Boackle RJ; Schwab JH
Infect Immun; 1978 Jan; 19(1):296-303. PubMed ID: 415005
[TBL] [Abstract][Full Text] [Related]
2. Modulation of complement fixation and the phlogistic capacity of group A, B, and D streptococci by human lysozyme acting on their cell walls.
Spitznagel JK; Goodrum KJ; Warejcka DJ; Weaver JL; Miller HL; Babcock L
Infect Immun; 1986 Jun; 52(3):803-11. PubMed ID: 3086232
[TBL] [Abstract][Full Text] [Related]
3. In vivo changes in complement induced with peptidoglycan-polysaccharide polymers from streptococcal cell walls.
Lambris JD; Allen JB; Schwab JH
Infect Immun; 1982 Jan; 35(1):377-80. PubMed ID: 7033141
[TBL] [Abstract][Full Text] [Related]
4. Nonspecific complement activation by streptococcal structures. II. Properdin-independent initiation of the alternate pathway.
Tauber JW; Polley MJ; Zabriskie JB
J Exp Med; 1976 Jun; 143(6):1352-66. PubMed ID: 818335
[TBL] [Abstract][Full Text] [Related]
5. Activation of the human complement cascade by bacterial cell walls, peptidoglycans, water-soluble peptidoglycan components, and synthetic muramylpeptides--studies on active components and structural requirements.
Kawasaki A; Takada H; Kotani S; Inai S; Nagaki K; Matsumoto M; Yokogawa K; Kawata S; Kusumoto S; Shiba T
Microbiol Immunol; 1987; 31(6):551-69. PubMed ID: 3670125
[TBL] [Abstract][Full Text] [Related]
6. Occurrence of glucosamine residues with free amino groups in cell wall peptidoglycan from bacilli as a factor responsible for resistance to lysozyme.
Hayashi H; Araki Y; Ito E
J Bacteriol; 1973 Feb; 113(2):592-8. PubMed ID: 4632317
[TBL] [Abstract][Full Text] [Related]
7. Effect of muralytic enzyme degradation of streptococcal cell wall on complement activation in vivo and in vitro.
Janusz MJ; Eisenberg RA; Schwab JH
Inflammation; 1987 Mar; 11(1):73-85. PubMed ID: 3552978
[TBL] [Abstract][Full Text] [Related]
8. Activation of the alternate complement pathway by peptidoglycan of Actinomyces viscosus, a potentially pathogenic oral bacterium.
Baker JJ; Billy SA
Arch Oral Biol; 1983; 28(11):1073-5. PubMed ID: 6362630
[TBL] [Abstract][Full Text] [Related]
9. Arthropathic group A streptococcal cell walls require specific antibody for activation of human complement by both the classical and alternative pathways.
Eisenberg RA; Schwab JH
Infect Immun; 1986 Aug; 53(2):324-30. PubMed ID: 3089935
[TBL] [Abstract][Full Text] [Related]
10. Function of the classical and alternate pathways of human complement in serum treated with ethylene glycol tetraacetic acid and MgCl2-ethylene glycol tetraacetic acid.
Des Prez RM; Bryan CS; Hawiger J; Colley DG
Infect Immun; 1975 Jun; 11(6):1235-43. PubMed ID: 806523
[TBL] [Abstract][Full Text] [Related]
11. Soluble peptidoglycan-polysaccharide fragments of the bacterial cell wall induce acute inflammation.
Chetty C; Klapper DG; Schwab JH
Infect Immun; 1982 Dec; 38(3):1010-9. PubMed ID: 6759402
[TBL] [Abstract][Full Text] [Related]
12. Arthropathic properties related to the molecular weight of peptidoglycan-polysaccharide polymers of streptococcal cell walls.
Fox A; Brown RR; Anderle SK; Chetty C; Cromartie WJ; Gooder H; Schwab JH
Infect Immun; 1982 Mar; 35(3):1003-10. PubMed ID: 7040244
[TBL] [Abstract][Full Text] [Related]
13. Lysozyme substrates.
Höltje JV
EXS; 1996; 75():105-10. PubMed ID: 8765297
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of macrophage phagocytic activity by group A streptococcal cell walls.
Smialowicz RJ; Schwab JH
Infect Immun; 1978 Apr; 20(1):258-61. PubMed ID: 352930
[TBL] [Abstract][Full Text] [Related]
15. The use of lysozyme-peroxidase-conjugates for the electron microscopic detection of peptidoglycan in the cell wall of streptococci.
Wagner M; Wagner B
Zentralbl Bakteriol Orig A; 1978 Apr; 240(3):302-12. PubMed ID: 352034
[TBL] [Abstract][Full Text] [Related]
16. Immunochemistry of the streptococcal group R cell wall polysaccharide antigen.
Soprey P; Slade HD
Infect Immun; 1972 Jan; 5(1):91-7. PubMed ID: 4632470
[TBL] [Abstract][Full Text] [Related]
17. Lysis of modified walls from Lactobacillus fermentum.
Logardt IM; Neujahr HY
J Bacteriol; 1975 Oct; 124(1):73-7. PubMed ID: 1176437
[TBL] [Abstract][Full Text] [Related]
18. Biological characteristics of peptidoglycans of group A streptococcus and some other bacterial species. II. Immunological mechanisms involved in thrombocytolysis.
Rýc M; Rotta J
J Hyg Epidemiol Microbiol Immunol; 1978; 22(4):435-41. PubMed ID: 38280
[TBL] [Abstract][Full Text] [Related]
19. Factors affecting complement activation by Staphylococcus aureus cell walls, their components, and mutants altered in teichoic acid.
Wilkinson BJ; Kim Y; Peterson PK
Infect Immun; 1981 Apr; 32(1):216-24. PubMed ID: 7216486
[TBL] [Abstract][Full Text] [Related]
20. Activation of the classic and alternate complement pathways by endotoxin.
Fine DP
J Immunol; 1974 Feb; 112(2):763-9. PubMed ID: 4205207
[No Abstract] [Full Text] [Related]
[Next] [New Search]
